Alpha Pro Tech Ltd (APT) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Alpha Pro Tech Ltd   (NYSEAMER: APT)

Alpha Pro Tech Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Alpha Pro Tech Ltd in the second quarter 2026?
Alpha Pro Tech Ltd achieved a return on average equity (ROE) of 15.43 % in its second quarter 2026, which is below Alpha Pro Tech Ltd 's average return on equity, which stands at 19.97%.

ROE has advanced compared to 13.43% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 24 other companies had a higher return on equity. While the total ranking for ROE unchanged, relative to the first quarter 2026 at no. 1052.

What is ROE?




Return On Equity (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Equity Change 4.29 % 2.08 % 0.39 % 0.77 % -
Y / Y Net Income Change 47.46 % 14.58 % -12.25 % 15.71 % -24.13 %
Net Income (TTM) in Millions 10 8 8 8 8
Return On Equity (TTM) 15.43 % 13.43 % 13.17 % 13.57 % 13.1 %
APT's Total Ranking # 1052 # 1052 # 815 # 863 # 893
Equity (TTM) in Millions 65 63 62 63 62
Seq. Equity Change 3.03 % 0.86 % -0.1 % 0.47 % 0.84 %
Seq. Net Income Change 165.28 % -6.15 % -25.47 % -20.53 % 106.14 %

Return On Equity Company Ranking
Within: No.
Industry # 25
Sector # 106
Overall # 1052

Return On Equity Statistics
High Average Low
118.29 %
19.97 %
0.1 %
(Dec 31 2020)   (Dec 31 2021)





APT Annual Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Equity in Millions 62 62 62 61 63
Y / Y Equity Change 0.39 % 1.08 % 1.33 % -2.97 % 4.33 %
Net Income in Millions 8 9 10 8 15
Y / Y Net Income Change -8.37 % -6.92 % 25.23 % -49.68 % -74.29 %
Return On Equity 13.12 % 14.38 % 15.62 % 12.64 % 24.36 %





Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 13.12 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
APT's' Return on Equity at Yahoo Finance
APT's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for APT's Competitors
Subscribers only: Roe for Alpha Pro Tech Ltd 's Suppliers
Subscribers only: Return On Equity for APT's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %
Prestige Consumer Healthcare Inc   21.77 %


Date modified: 2026-09-08T16:32:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.